RM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy RM now for a near-term rebound setup. The stock is sitting just above first support (S1 35.58) with a mildly oversold RSI and a MACD downtrend that’s losing downside momentum, while hedge fund buying has surged and fundamentals just printed strong YoY growth. Upside is most likely a move back toward the pivot (~36.93) and then resistance near 38.29 if the bounce follows through.
Trend/price action: RM is trading at 36.11, below the pivot (36.933), which keeps the immediate bias slightly bearish-to-neutral, but it’s close to support (S1 35.58) where bounces often start. Momentum: MACD histogram is negative (-0.213) but negatively contracting, signaling downside momentum is fading (often a precursor to a short-term reversal). RSI: RSI(6) at 37.39 is weak but not deeply oversold; it supports a rebound thesis if price holds above S1. Moving averages: Converging moving averages suggests the prior trend is losing strength and a direction change is possible. Key levels: Support S1 35.58 (then S2 34.745). Resistance at pivot 36.933, then R1 38.285 and R2 39.12.
Intellectia Proprietary Trading Signals
Strong recent fundamentals (2025/Q3): revenue +13.09% YoY, net income +87.34% YoY, EPS +86.84% YoY.
Hedge funds are buying: purchase amount up 553.61% over the last quarter.
Technical setup supports a bounce: price is near S1 with fading downside MACD momentum.
Upcoming earnings event: QDEC 2025 earnings on 2026-02-04 after hours (can act as a catalyst as the date approaches).
Insiders are selling: selling amount up 476.43% over the last month (a meaningful negative signal).
No supportive news flow in the past week (no fresh narrative catalyst).
Price is still below the pivot and MACD remains negative, so the broader near-term trend hasn’t fully flipped bullish yet.
Options liquidity/flow is minimal today (volume ~0), so the put/call read is more positioning than active conviction.
Latest reported quarter: 2025/Q3. Growth trends were notably strong: Revenue rose to 165.487M (+13.09% YoY). Net income increased to 14.356M (+87.34% YoY). EPS increased to 1.42 (+86.84% YoY). This combination points to strong profitability expansion relative to revenue growth, which is supportive for the stock into the next earnings cycle.
No analyst rating or price target change data was provided, so a recent Wall Street upgrade/downgrade trend can’t be confirmed here. Based on the data available: pros would be accelerating earnings power and evident institutional (hedge fund) accumulation; cons would be heavy insider selling and a chart that’s only starting to stabilize rather than clearly trending up. No recent politician/congress trading activity was reported in the last 90 days.
